Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Growth hormone pretreatment duration for improving embryo quality in IVF
ChiCTR2600124857Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Wenzhou Medical University
- Start
- May 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of somatropin in female infertility (2 arms), sponsored by The First Affiliated Hospital of Wenzhou Medical University. Primary endpoint: Clinical pregnancy rate in the first embryo transfer cycle. Planned start May 2026; status: not yet recruiting.
02
Drugs
somatropin
03
Conditions
female infertility
Beyond the preview
Go deeper on ChiCTR2600124857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600124857.